Artia Global Partners’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$38.1M Hold
185,390
– – 7.68% 2
2026
Q2
$34.7M Buy
185,390
+60,400
+48% +$8.82M 6.41% 5
2026
Q1
$12.2M Buy
124,990
+20,800
+20% +$2.1M 2.43% 10
2025
Q4
$8.3M Hold
104,190
– – 1.18% 17
2025
Q3
$4.87M Hold
104,190
– – 0.77% 20
2025
Q2
$3.83M Hold
104,190
– – 0.92% 18
2025
Q1
$3.68M Sell
104,190
-180,000
-63% -$7.31M 0.93% 19
2024
Q4
$12.4M Buy
284,190
+188,305
+196% +$9.5M 4.44% 11
2024
Q3
$4.35M Buy
+95,885
New +$4.18M 1.19% 15

Other funds holding RVMD

Artia Global Partners's RVMD Position: Q3 2026 in Review

Artia Global Partners held its Revolution Medicines (RVMD) position steady in Q3 2026 at 185,390 shares worth $38.1M. The position accounts for 7.68% of the portfolio, ranked #2.

Artia Global Partners first reported a position in RVMD in Q3 2024 and has held it in 9 quarters since. 759 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Artia Global Partners held 185,390 shares of Revolution Medicines worth $38.1M as of Q3 2026.
  • Artia Global Partners left its Revolution Medicines share count unchanged in Q3 2026.
  • Revolution Medicines made up 7.68% of Artia Global Partners's portfolio in Q3 2026, its #2 holding.
  • Artia Global Partners first reported a position in Revolution Medicines in Q3 2024 and has held it in 9 quarters since.
  • 759 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Artia Global Partners's 13F filing for Q3 2026, filed 16 Nov 2026.